The Role of Cytoreductive Surgery in Cancers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 176

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
Interests: CRS/HIPEC; cancer

Special Issue Information

Dear Colleagues,

This Special Issue "The Role of Cytoreductive Surgery in Cancers" explores the significance and impact of cytoreductive surgery on various types of cancer. This collection of articles delves into this surgical approach and its outcomes. It focuses on the role of cytoreduction in improving the survival rates, reducing the tumor burden, and enhancing the effectiveness of other treatment modalities, such as chemotherapy and radiation therapy. We also discuss the challenges and limitations associated with cytoreductive surgery, as well as the potential strategies employed to overcome them. Overall, this Special Issue provides valuable insights into the evolving field of cytoreductive surgery and its potential to revolutionize cancer treatment by targeting the primary tumor site and minimizing the risk of metastasis.

Dr. Andreas Bremers
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor metastasis
  • cytoreductive surgery (CRS)
  • hyperthermic intraperitoneal chemotherapy (HIPEC)
  • cytoreductive surgery
  • cancer

Published Papers

This special issue is now open for submission.
Back to TopTop